Source: British Journal of Pharmacology. Unidade: FMRP
Subjects: ENDOTÉLIO VASCULAR, ADENOSINA, HIPERTENSÃO, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATSUMOTO, Takayuki et al. Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes. British Journal of Pharmacology, v. 172, n. 16, p. 3980-4001, 2015Tradução . . Disponível em: https://doi.org/10.1111/bph.13205. Acesso em: 16 nov. 2024.APA
Matsumoto, T., Goulopoulou, S., Taguchi, K., Tostes, R. de C. A., & Kobayashi, T. (2015). Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes. British Journal of Pharmacology, 172( 16), 3980-4001. doi:10.1111/bph.13205NLM
Matsumoto T, Goulopoulou S, Taguchi K, Tostes R de CA, Kobayashi T. Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes [Internet]. British Journal of Pharmacology. 2015 ; 172( 16): 3980-4001.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/bph.13205Vancouver
Matsumoto T, Goulopoulou S, Taguchi K, Tostes R de CA, Kobayashi T. Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes [Internet]. British Journal of Pharmacology. 2015 ; 172( 16): 3980-4001.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/bph.13205
